Conference abstract · 2018
Conference abstractPublished 14 Sep 2016
BBB a gateway for neurodegeneration-neuroprotection
Uppsala University, Sweden
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Recent advancements in bionanotechnology lead to the development of several nanoformulation to deliver drugs to the central nervous system (CNS) for enhancing the therapeutic potential of the parent compounds. Nanodrug delivery could allow the active compounds to enter faster in the CNS in high quantity and may remain there for prolonged periods of time due to slower degradation resulting in enhanced therapeutic effects. For this purpose, several techniques for nanodrug delivery are used e.g., incorporation of drugs into soft nanoparticles, carbon nanotube as well as tagging them to nanowires made from different nanomaterials viz., SiO2, Cu, Ag, or Al. However, the neurotoxic effects of nanomaterials per se on the CNS structure or function are still not well investigated. Thus, the need of the hour is to evaluate possible effects of nanomaterials on the neurotoxicity of the CNS before they are used for neurorepair. In this regard microscopy is the only technique that can precisely focus on the structural alterations of the CNS components following nanodrug delivery for neurorepair purposes. Since last decade, our laboratory is engaged in exploring the role of nanoparticles and/or nanowired drug delivery on structural changes on the CNS in animal models using both light and electron microscopy in vivo situations. In this review salient features of nanoneurotoxicity and nanoneuroprotection as revealed by microscopical techniques are discussed.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2016
Neuroprotective effect of a new peptide against neurodegeneration induced in the murine model of Parkinsons disease
Conference abstract · 2015
Disease-modifying neuroprotective action of the agent Dimebon (latrepirdine) in animal models of neurodegeneration
Short communication · 2021
Prokineticin 2: A Chemokine Swinging Between Neuroprotection and Neurodegeneration
Conference abstract · 11 Jul 2016
The neuroprotective effect of Tocotrienol in chronic cerebral hypoperfusion-induced neurodegeneration in rats
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Hari Shanker Sharma”
